MetLife financials
$95.20−0.65%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19.15B | $19.07B | $23.81B | $17.36B | $17.34B | $18.57B | $18.67B | $18.44B | $17.82B | $16.06B | $19.03B | $15.87B |
| Gross profit | $7.82B | $7.21B | $7.04B | $6.99B | $6.57B | $6.76B | $6.09B | $7.84B | $6.34B | $5.98B | $7.21B | $4.75B |
| Gross margin | 40.8% | 37.8% | 29.6% | 40.3% | 37.9% | 36.4% | 32.6% | 42.5% | 35.6% | 37.3% | 37.9% | 30.0% |
| Operating income | $1.03B | $1.49B | $1.30B | $1.05B | $980.0M | $1.32B | $1.54B | $1.86B | $1.20B | $1.04B | $941.0M | $534.0M |
| Net income | $705.0M | $1.14B | $778.0M | $818.0M | $698.0M | $879.0M | $1.24B | $1.27B | $912.0M | $800.0M | $574.0M | $422.0M |
| Net margin | 3.7% | 6.0% | 3.3% | 4.7% | 4.0% | 4.7% | 6.6% | 6.9% | 5.1% | 5.0% | 3.0% | 2.7% |
| Diluted EPS | $1.09 | $1.74 | $1.18 | $1.22 | $1.03 | $1.28 | $1.78 | $1.81 | $1.28 | $1.10 | $0.77 | $0.56 |
| EBITDA | $783.0M | $1.49B | -$443.0M | $1.05B | $708.0M | $1.32B | -$568.0M | $1.86B | $1.20B | $1.04B | -$98.0M | $534.0M |
| Operating cash flow | $2.23B | $2.69B | $7.08B | $3.57B | $2.19B | $4.26B | $4.61B | $4.17B | $3.49B | $2.33B | $5.18B | $3.48B |
| Free cash flow | $2.23B | $2.69B | $7.08B | $3.57B | $2.19B | $4.26B | $4.61B | $4.17B | $3.49B | $2.33B | $5.18B | $3.48B |
| Diluted shares | 646.9M | 655.7M | 662.1M | 669.1M | 675.0M | 687.0M | 697.6M | 703.7M | 714.7M | 728.4M | 742.9M | 755.5M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $19.30B | $22.69B | $22.03B | $20.23B | $22.18B | $21.33B |
| Short-term investments | $156.85B | $147.69B | $151.93B | $146.34B | $143.18B | $138.14B |
| Total debt | $21.63B | $21.43B | $20.54B | $20.23B | $20.34B | $19.69B |
| Total assets | $759.37B | $743.21B | $745.17B | $719.73B | $702.47B | $688.32B |
| Total liabilities | $731.41B | $715.41B | $716.25B | $690.53B | $674.54B | $660.56B |
| Shareholders' equity | $27.74B | $27.80B | $28.68B | $29.19B | $27.93B | $27.75B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology